1. Home
  2. AVDL vs ASGN Comparison

AVDL vs ASGN Comparison

Compare AVDL & ASGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.51

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo ASGN Incorporated

ASGN

ASGN Incorporated

HOLD

Current Price

$49.04

Market Cap

2.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVDL
ASGN
Founded
2015
1985
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.1B
IPO Year
1996
1992

Fundamental Metrics

Financial Performance
Metric
AVDL
ASGN
Price
$21.51
$49.04
Analyst Decision
Buy
Hold
Analyst Count
9
5
Target Price
$18.38
$48.60
AVG Volume (30 Days)
1.6M
459.1K
Earning Date
03-02-2026
02-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.96
Revenue
$248,517,000.00
$3,985,300,000.00
Revenue This Year
$65.47
N/A
Revenue Next Year
$30.88
$0.57
P/E Ratio
N/A
$16.57
Revenue Growth
79.88
N/A
52 Week Low
$6.38
$39.25
52 Week High
$23.57
$95.29

Technical Indicators

Market Signals
Indicator
AVDL
ASGN
Relative Strength Index (RSI) 56.85 52.64
Support Level $21.45 $48.78
Resistance Level $21.60 $50.12
Average True Range (ATR) 0.08 1.48
MACD -0.05 -0.10
Stochastic Oscillator 48.78 55.84

Price Performance

Historical Comparison
AVDL
ASGN

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About ASGN ASGN Incorporated

ASGN Inc is a provider of information technology (IT) services and professional solutions, including technology, creative, and digital, across the commercial and government sectors. It operates through two segments, Commercial and Federal Government. The Commercial Segment, which generates the majority of the revenue, provides consulting, creative digital marketing, and permanent placement services to Fortune 1000 clients and mid-market companies. The Federal Government Segment provides mission-critical solutions to the Department of Defense, intelligence agencies, and civilian agencies.

Share on Social Networks: